IgA recovery of patients with IgG myeloma
| IgA at different time points . | -exT (estimated), mg/dL (n = 64) . | +exT (estimated), mg/dL (n = 36) . | P . |
|---|---|---|---|
| Day 60 | 71.7 | 129.8 | .004 |
| Day 100 | 59.4 | 114.4 | .008 |
| Day 180 | 48.7 | 98.4 | .004 |
| IgA at different time points . | -exT (estimated), mg/dL (n = 64) . | +exT (estimated), mg/dL (n = 36) . | P . |
|---|---|---|---|
| Day 60 | 71.7 | 129.8 | .004 |
| Day 100 | 59.4 | 114.4 | .008 |
| Day 180 | 48.7 | 98.4 | .004 |
Estimated values for polyclonal IgA among 36 patients with evaluable IgG (or light chain only) myeloma in current trial who received expanded T cells (+exT) compared with 64 patients with IgG (or light chain only) myeloma in the historical database who did not receive expanded T cells (-exT) at days 60, 100, and 180 after transplantation. P values were significant at each day analyzed.